Herbal Monograph
Turmeric
Curcuma longa L.
Zingiberaceae (Ginger family)
Potent anti-inflammatory powerhouse and digestive support herb with over 5,000 years of traditional use
Overview
Plant Description
Turmeric (Curcuma longa) is a perennial herbaceous plant of the ginger family whose rhizome has been used for over 5,000 years in Ayurvedic and traditional Asian medicine. It is one of the most extensively researched botanical medicines in the world, with over 12,000 peer-reviewed publications investigating its pharmacology. The principal bioactive constituents are the curcuminoids, particularly curcumin (diferuloylmethane), which is responsible for the characteristic deep yellow-orange color and many of the plant's therapeutic properties. Turmeric is approved by the German Commission E for dyspeptic complaints and is included in the WHO and ESCOP monograph systems. A critical pharmacological consideration is the extremely poor oral bioavailability of curcumin, which limits its systemic activity unless specific absorption-enhancing strategies (piperine co-administration, lipid formulation, nanoparticle delivery) are employed. Erect perennial herb growing 60-100 cm tall. Large oblong leaves emerge from the pseudostem, bright green above and paler beneath. Inflorescence is a central spike bearing pale yellow flowers with green and pink bracts. The rhizome is the medicinally important part: thick, cylindrical, branched, with a rough segmented skin ranging from brown to yellowish-brown externally and a deep orange-yellow internally. When cut, the rhizome exudes an intensely colored juice that stains surfaces readily.
Habitat
Native to the Indian subcontinent and Southeast Asia. Requires a warm, humid tropical climate with temperatures of 20-30 degrees Celsius, well-distributed rainfall (1500-2250 mm annually), and well-drained, fertile loamy or alluvial soils. Commercially cultivated primarily in India (which produces over 75% of the global supply), Bangladesh, Pakistan, Sri Lanka, Indonesia, China, Thailand, and parts of tropical Africa and the Caribbean. Grows at elevations from sea level to approximately 1500 m.
Parts Used
Rhizome (fresh or dried)
The rhizome is the official drug part in all pharmacopeial and monograph systems (Commission E, WHO, ESCOP, EMA). Fresh rhizome is used in traditional cooking and some traditional medicine preparations. Dried rhizome is typically boiled or steamed, then dried and ground. Both whole rhizome (containing curcuminoids, essential oil, polysaccharides, and other constituents) and curcumin-standardized extracts are used therapeutically.
Key Constituents
Curcuminoids
Sesquiterpenes (essential oil)
Polysaccharides
Other constituents
Essential oil
Herbal Actions
Relieves smooth muscle spasm
[2]Therapeutic Indications
Digestive System
Dyspepsia and digestive discomfort
Commission E positive monograph for dyspeptic complaints. WHO monograph confirms use for acid, flatulent, and atonic dyspepsia. The choleretic/cholagogue effects increase bile flow, improving fat digestion and reducing post-prandial bloating and discomfort. The carminative effects of the essential oil further support digestive function. This is the best-established clinical indication for whole turmeric rhizome.
[1, 2, 15]Irritable bowel syndrome (IBS)
A partially blinded, randomized pilot study by Bundy et al. (2004) found that turmeric extract (72 mg curcumin, 2 tablets daily for 8 weeks) significantly reduced IBS symptom prevalence and improved quality of life scores. Anti-inflammatory and antispasmodic effects may benefit IBS pathophysiology. Further adequately powered trials are needed.
[14]Inflammatory bowel disease (ulcerative colitis, adjunctive)
Hanai et al. (2006) RCT found curcumin (1 g twice daily) as adjunctive therapy to mesalamine significantly reduced relapse rate in ulcerative colitis patients during 6-month follow-up (4.65% relapse vs 20.51% placebo, P = 0.040). Lang et al. (2015) open-label study reported improved clinical and endoscopic outcomes with curcumin add-on therapy. These are adjunctive uses alongside standard medical therapy, not monotherapy.
[10, 20]Musculoskeletal System
Osteoarthritis pain and inflammation
Daily et al. (2016) meta-analysis of 8 RCTs (n=606) concluded curcuminoid preparations significantly reduced pain (WOMAC and VAS scores) and improved physical function in osteoarthritis, with efficacy comparable to NSAIDs (ibuprofen, diclofenac) in head-to-head trials. Kuptniratsaikul et al. (2014) found Curcuma domestica extract (1500 mg/day) equivalent to ibuprofen (1200 mg/day) for knee OA pain and function over 4 weeks. This is one of the strongest clinical evidence bases for curcumin.
[6, 8, 20]Rheumatoid arthritis (adjunctive)
Chandran & Goel (2012) pilot RCT found curcumin (500 mg) was not only effective but showed statistically superior improvement in DAS-28 and ACR scores compared to diclofenac sodium (50 mg) in 45 patients with active RA over 8 weeks. However, this was a small pilot study. Anti-inflammatory mechanisms (NF-kB, TNF-alpha, IL-6 suppression) are relevant to RA pathophysiology. Adjunctive use alongside standard RA therapy, not monotherapy.
[9, 18]Exercise-induced muscle soreness and recovery
Hewlings & Kalman (2017) systematic review identified multiple RCTs demonstrating that curcumin supplementation reduces delayed-onset muscle soreness (DOMS) and inflammatory markers after intense exercise. The anti-inflammatory and antioxidant mechanisms are relevant. Doses of 150-1500 mg curcumin around exercise periods showed benefit.
[20]Hepatobiliary System
Hepatoprotection and liver support
Turmeric's hepatoprotective effects are mediated through antioxidant activity (Nrf2 pathway activation, glutathione enhancement), anti-inflammatory effects (NF-kB inhibition), and choleretic/cholagogue effects. Animal studies demonstrate protection against carbon tetrachloride, ethanol, aflatoxin, and drug-induced hepatotoxicity. Rivera-Espinoza & Muriel (2009) review catalogued extensive preclinical evidence. Human clinical data is emerging but less extensive than preclinical data.
[2, 22]Non-alcoholic fatty liver disease (NAFLD, preliminary)
Several recent RCTs have investigated curcumin for NAFLD with promising results including reduced hepatic fat content, improved liver enzymes, and reduced inflammatory markers. Rahmani et al. (2016) found curcumin (500 mg/day for 8 weeks) significantly reduced liver fat content by ultrasound. Further larger trials are needed to establish clinical recommendations.
[20]Cholelithiasis prevention and bile flow support
Turmeric's cholagogue and choleretic effects increase bile flow and may help prevent cholesterol gallstone formation by reducing biliary cholesterol saturation. Rasyid & Lelo (1999) demonstrated increased gallbladder contraction after turmeric consumption by ultrasound in healthy volunteers. IMPORTANT: Turmeric is CONTRAINDICATED in existing bile duct obstruction and should be used cautiously with gallstones, as increased bile flow could mobilize stones.
[1, 16]Cardiovascular System
Cardiovascular risk factor modification (dyslipidemia)
Multiple RCTs and meta-analyses demonstrate that curcumin supplementation can modestly improve lipid profiles, reducing total cholesterol, LDL-C, and triglycerides while increasing HDL-C in some studies. Curcumin also reduces oxidized LDL, a key driver of atherosclerosis. Effects are generally modest and most pronounced in metabolic syndrome and type 2 diabetes populations.
[18, 20]Endothelial function improvement
Curcumin improves endothelial function through enhancement of nitric oxide bioavailability, reduction of oxidative stress, and anti-inflammatory effects on vascular endothelium. Santos-Parker et al. (2017) found curcumin supplementation improved vascular endothelial function in healthy middle-aged and older adults. Preliminary evidence with cardiovascular relevance.
[20]Nervous System
Major depressive disorder (adjunctive)
Ng et al. (2017) meta-analysis of 6 RCTs (n=377) concluded that curcumin significantly reduced depressive symptoms compared to placebo, with greater efficacy when used alongside antidepressant medication (adjunctive use) and in longer treatment durations (>6 weeks). Proposed mechanisms include modulation of serotonin and dopamine, BDNF elevation, HPA axis normalization, and neuroinflammation reduction. Lopresti et al. (2014) found curcumin (500 mg twice daily) effective for major depression.
[7, 12]Cognitive function and neuroprotection (preliminary)
Curcumin crosses the blood-brain barrier and demonstrates neuroprotective properties in preclinical models including inhibition of amyloid-beta aggregation, tau phosphorylation reduction, and neuroinflammation suppression. Small et al. (2018) RCT found bioavailable curcumin (Theracurmin, 90 mg twice daily for 18 months) improved memory performance and reduced amyloid and tau accumulation in non-demented adults by PET scan. Promising but preliminary; large-scale trials needed.
[20]Skin / Integumentary
Wound healing (topical)
Topical turmeric paste has been applied to wounds, cuts, and burns across South and Southeast Asian traditions for millennia. Preclinical evidence supports enhanced wound closure through anti-inflammatory effects, increased collagen deposition, fibroblast proliferation, and angiogenesis. The antimicrobial activity provides additional benefit for contaminated wounds. Clinical data is limited but traditional use is extensive.
[2, 23]Inflammatory skin conditions (psoriasis, eczema — topical and oral)
Curcumin's inhibition of TNF-alpha, IL-17, and NF-kB targets key pathways in psoriasis and eczema pathophysiology. Several small clinical trials report improvement in psoriasis severity with oral curcumin supplementation. Topical turmeric preparations have shown benefit for various dermatological conditions in preliminary studies. More rigorous clinical trials are needed.
[20, 23]Immune System
Immune modulation and chronic inflammatory conditions
Curcumin's broad modulation of immune cell function (T cells, B cells, macrophages, dendritic cells, NK cells) and its effects on multiple inflammatory pathways position it as an immunomodulator rather than a simple immunostimulant. Useful for conditions characterized by chronic low-grade inflammation (metabolic syndrome, autoimmune conditions as adjunct). Turmeric polysaccharides provide additional immunomodulatory activity independent of curcuminoids.
[2, 18]Endocrine System
Metabolic syndrome and type 2 diabetes (adjunctive)
Multiple RCTs demonstrate curcumin supplementation improves fasting blood glucose, HbA1c, insulin resistance (HOMA-IR), and inflammatory markers in type 2 diabetes and metabolic syndrome. Chuengsamarn et al. (2012) RCT in 240 prediabetic subjects found curcumin (250 mg/day for 9 months) significantly reduced progression to type 2 diabetes. This is adjunctive to standard medical management, not a replacement for antidiabetic medication.
[13, 20]Energetics
Temperature
warm
Moisture
dry
Taste
Tissue States
damp, stagnant, congestive
In Ayurveda, turmeric (haridra) is classified as tikta (bitter), katu (pungent), and kashaya (mildly astringent) rasa; ushna (heating) virya; and katu (pungent) vipaka. It balances all three doshas but is particularly effective for reducing kapha (congestion, dampness) and regulating pitta (inflammation, liver heat). In Traditional Chinese Medicine, jiang huang (turmeric rhizome) is classified as acrid, bitter, and warm; it enters the Spleen and Liver channels, invigorates blood, promotes the movement of qi, and is used for blood stasis and epigastric pain. Western energetic assessment: warm and drying, indicated for cold, damp, stagnant tissue states with congestion and sluggish digestion.
Traditional Uses
Ayurvedic medicine (India, 5000+ years)
- Haridra (turmeric) used as a digestive aid and carminative for bloating, gas, and indigestion
- Anti-inflammatory for joint pain, arthritis, and muscular soreness
- Hepatoprotective and cholagogue for liver and gallbladder support
- Blood purifier (raktashodhak) for skin diseases and blood disorders
- Topical wound healing paste (fresh turmeric with ghee or honey) for cuts, burns, bruises
- Respiratory conditions: cough, asthma, bronchitis (with warm milk and ghee)
- Menstrual regulation and uterine stimulant
- General tonic and rasayana (rejuvenative) for longevity and vitality
- Cosmetic use: skin brightening, haldi ceremony in weddings
"Turmeric is one of the most important botanicals in Ayurveda, referenced in the earliest Ayurvedic texts including the Charaka Samhita and Sushruta Samhita (circa 1500-500 BCE). It is classified under the Haridra group and recommended for a vast range of conditions. The classical formulation 'Haridrakhanda' is specifically indicated for allergic conditions and skin diseases. Turmeric milk ('golden milk' or 'haldi doodh') is a traditional household remedy for colds, coughs, and general immune support."
Traditional Chinese Medicine
- Jiang huang (turmeric rhizome) used to invigorate blood circulation and break blood stasis
- Treatment of epigastric and abdominal pain due to qi and blood stagnation
- Chest pain and amenorrhea from blood stasis
- Traumatic injuries, swelling, and pain (topical and internal)
- Jaundice and liver disorders
- Shoulder and arm pain (channel tropism for the Liver and Spleen meridians)
"In TCM, jiang huang enters the Spleen and Liver channels. Its primary actions are to invigorate blood, promote qi movement, open the channels, and alleviate pain. It is classified as acrid and bitter in flavor, warm in nature. It is distinguished from yu jin (Curcuma wenyujin or C. longa tuber), which is considered cool and used more for clearing heat from the blood. Tang Ben Cao (659 CE) is among the earliest Chinese pharmacopeias to record turmeric's medicinal use."
Indonesian jamu (traditional medicine)
- Jamu kunyit asam (turmeric and tamarind tonic) for menstrual health and body slimming
- Digestive complaints, bloating, and nausea
- Liver protection and general detoxification
- Skin care and cosmetic brightening (lulur body scrub)
- Post-partum recovery and uterine involution
"Turmeric (kunyit) is foundational to Indonesian jamu tradition, which has been practiced for over a millennium. Jamu kunyit asam, a drink combining turmeric with tamarind and palm sugar, is one of the most popular jamu formulations, consumed daily by millions of Indonesians for health maintenance. Jamu gendong (mobile jamu vendors) traditionally carry fresh turmeric preparations."
[2]
Unani and Middle Eastern traditional medicine
- Digestive aid for dyspepsia and flatulence
- Liver and spleen disorders
- Topical application for skin diseases, wounds, and insect bites
- Anti-inflammatory for joint pain
- Used as 'zard chob' in Persian medicine for similar indications
"Turmeric has been used in Unani-Tibb medicine for centuries, primarily for digestive, hepatic, and inflammatory conditions. Ibn Sina (Avicenna) referenced turmeric in the Canon of Medicine for digestive and hepatic complaints. The warm, dry temperament classification in Unani aligns with Ayurvedic energetic assessment."
[17]
Modern Research
Curcumin: potential for cancer prevention and treatment (comprehensive review)
Comprehensive review of the molecular basis for curcumin's effects in cancer prevention and therapy, examining over 3000 studies on curcumin's anticancer properties and its modulation of multiple cell signaling pathways.
Findings: Curcumin was found to modulate growth factors (EGFR, PDGF, VEGF), transcription factors (NF-kB, AP-1, STAT3), enzymes (COX-2, MMP-9, telomerase), kinases (Akt, MAPK), and inflammatory cytokines. These pleiotropic effects suppress tumor initiation, promotion, and metastasis in preclinical models across nearly every cancer type studied. The review concluded curcumin is a promising multi-targeted agent but noted the critical bioavailability limitation.
Limitations: Review predominantly based on preclinical (in vitro and animal) data. The clinical relevance of many molecular targets at achievable human plasma concentrations is uncertain due to poor bioavailability. Most human cancer trials were early-phase or pilot studies at time of review.
[18]
Safety and anti-inflammatory activity of curcumin (critical review)
Critical review of the safety profile and anti-inflammatory mechanisms of curcumin, examining data from clinical trials, pharmacokinetic studies, and traditional use.
Findings: Curcumin was found to be safe at doses up to 8 g/day in short-term human studies. Anti-inflammatory activity was confirmed through multiple mechanisms: inhibition of COX-2, LOX, iNOS, and NF-kB; suppression of inflammatory cytokines. No dose-limiting toxicity was identified in Phase I clinical trials. GI side effects (nausea, diarrhea) were reported at very high doses (8-12 g/day) but generally well tolerated at standard therapeutic doses.
Limitations: Many safety studies were short-term (weeks to months). Long-term safety data at high doses was limited at time of review. Bioavailability challenge means serum concentrations remain very low even at high oral doses.
[19]
Curcumin for osteoarthritis: systematic review and meta-analysis
Systematic review and meta-analysis of randomized controlled trials evaluating the efficacy of curcuminoid preparations for osteoarthritis symptoms.
Findings: Meta-analysis of 8 RCTs (n=606) demonstrated that curcuminoid supplementation significantly reduced pain scores (WOMAC pain, VAS) and improved physical function compared to placebo. Effect sizes were clinically meaningful. In head-to-head comparisons with NSAIDs (ibuprofen, diclofenac), curcuminoid preparations showed comparable efficacy with fewer gastrointestinal side effects. Optimal dosing was approximately 1000 mg/day of curcuminoids for at least 8-12 weeks.
Limitations: Moderate heterogeneity in curcuminoid preparations (different formulations, bioavailability-enhancing technologies). Most studies had relatively small sample sizes. Publication bias could not be fully excluded. Duration of most trials was 4-16 weeks; long-term data limited.
[6]
Curcumin and depression: meta-analysis of randomized controlled trials
Meta-analysis of randomized controlled trials examining the efficacy of curcumin supplementation for depressive symptoms, including both curcumin monotherapy and adjunctive therapy alongside antidepressant medication.
Findings: Pooled analysis of 6 RCTs (n=377) found curcumin significantly reduced depressive symptoms compared to placebo (SMD = -0.34, 95% CI: -0.56 to -0.13). Greater effects were observed with adjunctive use (curcumin plus antidepressant) and with longer treatment durations (>6 weeks). Curcumin showed anxiolytic effects in a subgroup analysis. Proposed mechanisms include modulation of monoamine neurotransmitters, reduction of neuroinflammation, BDNF enhancement, and HPA axis regulation.
Limitations: Relatively small total sample size. Heterogeneity in curcumin preparations and doses (500-1500 mg/day). Most studies were conducted in mild-to-moderate depression. Varying use of bioavailability-enhancing formulations. Quality of included studies was moderate.
[7]
Curcumin for osteoarthritis of the knee: equivalence to ibuprofen
Randomized, non-inferiority trial comparing Curcuma domestica extract (1500 mg/day in 3 divided doses) to ibuprofen (1200 mg/day in 3 divided doses) for knee osteoarthritis in 367 patients over 4 weeks.
Findings: Curcuma domestica extract was shown to be non-inferior to ibuprofen for pain reduction on the WOMAC pain subscale. Both treatments showed comparable improvement in WOMAC pain, stiffness, and function scores. Fewer gastrointestinal adverse events were reported in the turmeric group (6.2% vs 15.0%), primarily abdominal pain/discomfort, though the difference was not statistically significant for individual GI symptoms.
Limitations: Relatively short duration (4 weeks). Non-inferiority design rather than superiority. Low-dose ibuprofen comparator. Single-center study in Thailand. Whole turmeric extract (not isolated curcumin).
[8]
Curcumin vs diclofenac in rheumatoid arthritis
Randomized, single-blind pilot study comparing curcumin (500 mg), diclofenac sodium (50 mg), and their combination in 45 patients with active rheumatoid arthritis over 8 weeks.
Findings: The curcumin group showed the highest percentage of improvement in DAS-28 (Disease Activity Score) and ACR criteria (American College of Rheumatology response criteria). Curcumin treatment was statistically superior to diclofenac in several measures. The curcumin group experienced significantly fewer adverse events than the diclofenac group. The combination group showed no significant advantage over curcumin alone.
Limitations: Very small sample size (n=45, 15 per group). Single-blind rather than double-blind. Pilot study requiring larger confirmatory trials. Single center. Short duration.
[9]
Piperine enhances curcumin bioavailability in humans
Controlled pharmacokinetic study measuring the effect of co-administered piperine (from Piper nigrum) on the oral bioavailability of curcumin in healthy human volunteers and rats.
Findings: Co-administration of piperine (20 mg) with curcumin (2 g) increased curcumin bioavailability by 2000% (20-fold) in human subjects. In rats, the increase was 154%. Piperine inhibits intestinal and hepatic glucuronidation, which is the major Phase II metabolic pathway limiting curcumin bioavailability. No adverse effects were observed. This study established the scientific basis for the widely adopted practice of combining turmeric with black pepper.
Limitations: Small sample size for human arm. Single-dose pharmacokinetic study. Long-term effects of sustained glucuronidation inhibition not assessed. Piperine may also affect metabolism of other drugs (CYP3A4, CYP2D6 inhibition).
[11]
Curcumin as adjunctive therapy for ulcerative colitis
Randomized, double-blind, placebo-controlled multicenter trial of curcumin as adjunctive therapy to mesalamine in 89 patients with quiescent ulcerative colitis over 6 months.
Findings: The curcumin group (1 g twice daily plus mesalamine) had a significantly lower relapse rate than placebo (4.65% vs 20.51%, P = 0.040). Curcumin group also showed significant improvement in the Clinical Activity Index and endoscopic index compared to placebo. Demonstrated that curcumin can be an effective and safe adjunctive therapy for maintaining remission in ulcerative colitis.
Limitations: Relatively small sample size (n=89). Japanese population; may not generalize across ethnicities. Six-month duration; longer maintenance data needed. Adjunctive to mesalamine only; not tested as monotherapy.
[10]
Curcumin for prevention of type 2 diabetes in prediabetic population
Randomized, double-blind, placebo-controlled trial of curcumin extract capsules (250 mg/day containing curcuminoids) in 240 prediabetic subjects over 9 months, assessing progression to type 2 diabetes.
Findings: After 9 months, 16.4% of the placebo group progressed to type 2 diabetes compared to 0% in the curcumin group (P < 0.001). The curcumin group showed significantly improved beta-cell function (HOMA-beta), reduced insulin resistance (HOMA-IR), and higher adiponectin levels. Curcumin also reduced inflammatory markers (C-reactive protein, TNF-alpha, IL-6).
Limitations: Single-center study in Thailand. Relatively young prediabetic population. The 0% conversion rate in the curcumin group is unusually strong and awaits independent replication. 9-month duration; longer follow-up needed to assess sustained benefit.
[13]
Preparations & Dosage
capsule-powder
Strength: Crude dried rhizome powder, approximately 3-5% curcuminoids by weight
Dried turmeric rhizome, ground to fine powder and encapsulated. This is the simplest preparation and retains the full spectrum of constituents (curcuminoids, essential oil, polysaccharides). For enhanced bioavailability, take with a meal containing fat and a source of piperine (black pepper). Some practitioners recommend combining turmeric powder with a small amount of ground black pepper (5-10% by weight) in capsules.
1-3 g dried rhizome powder daily, in divided doses (2-6 capsules of 500 mg)
2-3 times daily with meals
May be used long-term as a dietary supplement. For specific therapeutic goals, assess response after 4-8 weeks.
Not well-established for capsule form in children. Children over 6 may use 500-1000 mg daily under practitioner guidance.
Whole turmeric powder contains the full complement of constituents including essential oil (turmerones) and polysaccharides that are absent from standardized curcumin extracts. The essential oil fraction (particularly ar-turmerone) may enhance curcumin absorption from the whole rhizome compared to isolated curcumin. Commission E dosage recommendation is 1.5-3 g dried rhizome daily. WHO monograph recommends 1.5-3 g daily. Taking with dietary fat and black pepper significantly enhances absorption.
Standardized Extract
Strength: Standardized to 95% total curcuminoids (most common). DER approximately 25-50:1. Bioavailability varies dramatically by formulation: piperine combination ~20x, phytosome ~29x, nanoparticle ~27x, BCM-95 ~7x enhancement over standard curcumin.
Capsules or tablets containing concentrated turmeric extract standardized to curcuminoid content. Most clinical trials use extracts standardized to 95% total curcuminoids (curcumin, demethoxycurcumin, bisdemethoxycurcumin). Various bioavailability-enhanced formulations are available: curcumin with piperine (BioPerine), curcumin-phospholipid complex (Meriva/phytosome), nanoparticle curcumin (Theracurmin), curcumin with turmeric essential oil (BCM-95), and amorphous solid dispersion (NovaSOL).
500-2000 mg curcuminoids daily in divided doses. For standard 95% curcuminoid extract: 500 mg 2-3 times daily. For enhanced-bioavailability formulations, follow manufacturer dosing as potency varies significantly. Clinical trial doses: 500-1500 mg/day curcuminoids for most indications.
2-3 times daily, preferably with meals containing fat
Clinical trials have used 4 weeks to 9 months of continuous supplementation safely. For chronic conditions (OA, depression), minimum 8-12 weeks recommended for full assessment of benefit.
Not well-established for standardized extracts in children
CRITICAL BIOAVAILABILITY NOTE: Standard curcumin has extremely poor oral bioavailability (estimated <1% systemic absorption). For any systemic indication (joint inflammation, depression, metabolic effects), a bioavailability-enhanced formulation or piperine co-administration is essential. For local GI effects (dyspepsia, IBS, IBD), standard unenhanced curcumin may be effective as it acts directly on gastrointestinal tissue. The choice of formulation should match the clinical goal.
Tincture
Strength: 1:5, 60-70% ethanol (dried rhizome)
Hydroethanolic extraction of dried turmeric rhizome. Standard ratio 1:5 in 60-70% ethanol. Macerate for 2-4 weeks with daily agitation, then press and filter. The higher alcohol percentage (compared to many other tinctures) is necessary to extract both curcuminoids (poorly water-soluble) and essential oil components effectively.
2-5 mL (40-100 drops) three times daily
Three times daily before or with meals
May be used for extended periods. Reassess therapeutic need periodically.
Not commonly used in pediatric practice due to alcohol content. Children over 6: 1-2 mL diluted in water, under practitioner guidance.
Tincture preparation extracts curcuminoids and essential oil components more effectively than water-based preparations. The ethanolic medium provides some solubilization of the lipophilic curcuminoids. Traditional preparation method. Less commonly used than capsules or standardized extracts in modern practice, but provides good extraction of the full constituent spectrum.
Decoction
Strength: 3-5 g dried rhizome per 500 mL water
Add 1-2 teaspoons (3-5 g) of dried turmeric rhizome pieces or powder to 2 cups (500 mL) of water. Bring to a boil, then reduce to a simmer for 10-15 minutes. Strain. Adding a small amount of fat (coconut oil, ghee) and a pinch of black pepper to the warm decoction significantly enhances curcuminoid extraction and absorption. This is the basis for traditional 'golden milk' (turmeric in warm milk with fat and spices).
1 cup (250 mL) 2-3 times daily
2-3 times daily
May be used long-term as a daily health beverage
Children over 4: half-cup (125 mL) 1-2 times daily. Dilute further for younger children.
Decoction is the traditional preparation method in Ayurvedic medicine. Water alone extracts limited curcuminoids but effectively extracts polysaccharides, proteins (turmerin), and some volatile oil components. The traditional practice of adding fat (ghee, coconut oil) is pharmacologically sound as it solubilizes curcuminoids and the fat medium enhances intestinal absorption. 'Golden milk' (haldi doodh) combines turmeric decoction with warm milk, ghee, black pepper, and sometimes ginger, cinnamon, and honey.
Fresh Juice / Expressed Juice
Strength: Fresh rhizome juice, undiluted
Fresh turmeric rhizome is washed, peeled if desired, and pressed or juiced using a juicer. Can also be grated and squeezed through cheesecloth. Best consumed immediately as curcuminoids degrade with light and air exposure. CAUTION: Fresh turmeric juice stains everything intensely. Use gloves and protect surfaces.
5-15 mL (1-3 teaspoons) fresh juice daily, diluted in water or added to smoothies
1-2 times daily
May be used seasonally or long-term
Children over 6: 2.5-5 mL daily
Fresh turmeric juice retains volatile compounds that may be lost in drying and provides the full spectrum of constituents in their native state. Some traditional practitioners consider fresh preparations superior. Often combined with fresh ginger juice and lemon in 'wellness shots.' The fresh rhizome contains approximately 80% moisture, so fresh juice dosing is not directly comparable to dried rhizome weight.
[2]
Poultice
Strength: Paste consistency, approximately 1-2 tablespoons powder per application
Mix dried turmeric powder with warm water, honey, ghee, or aloe vera gel to form a thick paste. Apply directly to the affected area and cover with a clean cloth or bandage. For joint pain: mix turmeric powder with warm sesame oil. Leave in place for 20-60 minutes. Rinse off with warm water. CAUTION: Turmeric paste will stain skin yellow temporarily (1-3 days) and will permanently stain fabrics.
Apply paste to affected area 1-2 times daily
1-2 times daily
Until condition resolves. Consult healthcare provider if no improvement after 1-2 weeks.
Suitable for children. Patch test first for skin sensitivity.
Topical turmeric paste is one of the oldest documented preparations, used across South and Southeast Asian traditions for wounds, inflammatory skin conditions, joint pain, and cosmetic purposes. The direct anti-inflammatory, antimicrobial, and wound-healing effects of curcumin are relevant for topical applications where systemic bioavailability is not a concern. Traditional Ayurvedic formulations combine turmeric with sesame oil, ghee, or honey as carriers.
Essential Oil
Strength: 100% essential oil (Curcumae longae aetheroleum). Major components: ar-turmerone, alpha-turmerone, beta-turmerone.
Obtained by steam distillation of dried or fresh turmeric rhizome. For topical use: dilute to 1-3% in a carrier oil (coconut, sesame, jojoba). For aromatherapy: use in a diffuser at manufacturer-recommended amounts. NOT for undiluted topical application or internal use without professional guidance.
Topical: 1-3% dilution in carrier oil, applied to affected area 2-3 times daily. Aromatherapy: 3-5 drops in diffuser.
2-3 times daily for topical application
Short-term topical use. Reassess if condition does not improve within 1-2 weeks.
Topical: 0.5-1% dilution for children over 6. Not for use in children under 2.
Turmeric essential oil is rich in sesquiterpenes (turmerones) and contains minimal curcuminoids (which are not volatile). The turmerones have independent anti-inflammatory, neuroprotective, and antimicrobial properties. Some commercial formulations combine curcumin extract with turmeric essential oil (e.g., BCM-95) to enhance bioavailability, as ar-turmerone may facilitate curcumin absorption. The essential oil is golden-yellow (not to be confused with the deep orange of curcumin).
[24]
Safety & Interactions
Class 2b
Not to be used during lactation (AHPA Botanical Safety Handbook)
Contraindications
Turmeric's potent cholagogue effect stimulates bile flow and gallbladder contraction. In the presence of bile duct obstruction (by gallstones, tumor, or stricture), this action can exacerbate obstruction, cause severe biliary colic, or precipitate acute cholangitis. Commission E explicitly contraindicates turmeric in bile duct obstruction. WHO monograph concurs. This is the most critical safety concern for turmeric.
Allergic contact dermatitis to turmeric has been documented, though rare. Patients with known allergy to turmeric, ginger, or other Zingiberaceae plants should avoid use. Occupational contact dermatitis is reported in turmeric processing workers.
Drug Interactions
| Drug / Class | Severity | Mechanism |
|---|---|---|
| Warfarin and anticoagulant/antiplatelet agents (Anticoagulants/Antiplatelets) | moderate | Curcumin inhibits platelet aggregation in vitro through effects on thromboxane A2 and platelet activating factor. May also inhibit CYP enzymes involved in warfarin metabolism (CYP2C9, CYP1A2). Additive anticoagulant effect is theoretically possible. Case reports of elevated INR with concomitant turmeric and warfarin exist. |
| Antidiabetic medications (metformin, sulfonylureas, insulin) (Hypoglycemic agents) | moderate | Curcumin has demonstrated blood glucose-lowering effects in multiple clinical trials. Additive hypoglycemic effect possible when combined with antidiabetic medications. Chuengsamarn et al. (2012) demonstrated significant glucose-lowering and insulin-sensitizing effects. |
| CYP3A4, CYP1A2, CYP2C9 substrates (narrow therapeutic index drugs) (Various (statins, calcium channel blockers, immunosuppressants)) | theoretical | In vitro studies indicate curcumin inhibits CYP3A4, CYP1A2, CYP2C9, and CYP2D6. Piperine (commonly co-administered with curcumin for bioavailability) also inhibits CYP3A4, CYP2D6, and P-glycoprotein. The combination could theoretically increase plasma levels of drugs metabolized by these pathways. |
| NSAIDs (ibuprofen, naproxen, diclofenac) (Non-steroidal anti-inflammatory drugs) | minor | Additive anti-inflammatory and antiplatelet effects. Both curcumin and NSAIDs inhibit COX enzymes and platelet aggregation. Additive GI mucosal effects are possible, though curcumin is generally gastroprotective rather than gastrotoxic. |
| Chemotherapy agents (general consideration) (Antineoplastic agents) | theoretical | Curcumin may theoretically enhance or inhibit the effects of certain chemotherapy agents through effects on NF-kB, drug efflux pumps (P-glycoprotein), and apoptotic pathways. Some preclinical studies suggest synergy (enhanced cytotoxicity), while others raise concern about reduced efficacy of certain alkylating agents. |
Pregnancy & Lactation
Pregnancy
possibly unsafe
Lactation
insufficient data
AHPA Class 2b: not to be used during pregnancy without professional supervision. Culinary amounts of turmeric are considered safe during pregnancy and have been consumed by millions of women in India and Southeast Asia for millennia without documented teratogenic effects. However, high-dose curcumin supplements are a concern: curcumin has demonstrated uterine stimulant activity in animal models, and theoretical emmenagogue effects could increase miscarriage risk in early pregnancy. Commission E does not list specific pregnancy warnings but the cholagogue indication implies therapeutic doses. WHO monograph notes insufficient data on pregnancy safety for therapeutic doses. The distinction between food-level turmeric (safe, long traditional history) and high-dose curcumin supplements (insufficient safety data, theoretical concern) is critical. Lactation: insufficient specific data on curcumin excretion in breast milk. Culinary turmeric is widely consumed by breastfeeding women without reported adverse effects on infants.
Adverse Effects
References
Monograph Sources
- [1] German Commission E (Bundesinstitut fur Arzneimittel und Medizinprodukte). Commission E Monograph: Curcumae longae rhizoma (Turmeric Root) -- Positive. Bundesanzeiger (Federal Gazette) (1985)
- [2] World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 1: Rhizoma Curcumae Longae. World Health Organization, Geneva (1999) : 115-124
- [3] Hoffmann D. Medical Herbalism: The Science and Practice of Herbal Medicine. Healing Arts Press, Rochester, VT (2003) . ISBN: 978-0892817498
- [4] Blumenthal M, Busse WR, Goldberg A, Gruenwald J, Hall T, Riggins CW, Rister RS (eds). The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX (1998) . ISBN: 978-0965555500
- [5] Bensky D, Clavey S, Stoger E. Chinese Herbal Medicine: Materia Medica, Third Edition. Eastland Press, Seattle (2004) . ISBN: 978-0939616428
Clinical Studies
- [6] Daily JW, Yang M, Park S. Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. J Med Food (2016) ; 19 : 717-729 . DOI: 10.1089/jmf.2016.3705 . PMID: 27533649
- [7] Ng QX, Koh SSH, Chan HW, Ho CYX. Clinical Use of Curcumin in Depression: A Meta-Analysis. J Am Med Dir Assoc (2017) ; 18 : 503-508 . DOI: 10.1016/j.jamda.2016.12.071 . PMID: 28236605
- [8] Kuptniratsaikul V, Dajpratham P, Taechaarpornkul W, Buntragulpoontawee M, Lukkanapichonchut P, Chootip C, Saengsuwan J, Tantayakom K, Laongpech S. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. Clin Interv Aging (2014) ; 9 : 451-458 . DOI: 10.2147/CIA.S58535 . PMID: 24672232
- [9] Chandran B, Goel A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res (2012) ; 26 : 1719-1725 . DOI: 10.1002/ptr.4639 . PMID: 22407780
- [10] Hanai H, Iida T, Takeuchi K, Watanabe F, Maruyama Y, Andoh A, Tsujikawa T, Fujiyama Y, Mitsuyama K, Sata M, Yamada M, Iwaoka Y, Kanke K, Hiraishi H, Hirayama K, Arai H, Yoshii S, Uchijima M, Nagata T, Koide Y, Sugimoto K. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol (2006) ; 4 : 1502-1506 . DOI: 10.1016/j.cgh.2006.08.008 . PMID: 17101300
- [11] Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med (1998) ; 64 : 353-356 . DOI: 10.1055/s-2006-957450 . PMID: 9619120
- [12] Lopresti AL, Maes M, Maker GL, Hood SD, Drummond PD. Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study. J Affect Disord (2014) ; 167 : 368-375 . DOI: 10.1016/j.jad.2014.06.001 . PMID: 25046624
- [13] Chuengsamarn S, Rattanamongkolgul S, Luechapudiporn R, Phisalaphong C, Jirawatnotai S. Curcumin extract for prevention of type 2 diabetes. Diabetes Care (2012) ; 35 : 2121-2127 . DOI: 10.2337/dc12-0116 . PMID: 22773702
- [14] Bundy R, Walker AF, Middleton RW, Booth J. Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults: a pilot study. J Altern Complement Med (2004) ; 10 : 1015-1018 . DOI: 10.1089/acm.2004.10.1015 . PMID: 15673996
- [15] Thamlikitkul V, Bunyapraphatsara N, Dechatiwongse T, Theerapong S, Chantrakul C, Thanaveerasuwan T, Nimitnon S, Boonroj P, Punkrut W, Gingsungnoen V. Randomized double blind study of Curcuma domestica Val. for dyspepsia. J Med Assoc Thai (1989) ; 72 : 613-620 . PMID: 2699615
- [16] Rasyid A, Lelo A. The effect of curcumin and placebo on human gall-bladder function: an ultrasound study. Aliment Pharmacol Ther (1999) ; 13 : 245-249 . DOI: 10.1046/j.1365-2036.1999.00464.x . PMID: 10102956
Traditional Texts
- [17] Prasad S, Aggarwal BB. Turmeric, the Golden Spice: From Traditional Medicine to Modern Medicine. In: Benzie IFF, Wachtel-Galor S (eds). Herbal Medicine: Biomolecular and Clinical Aspects, 2nd edition. CRC Press/Taylor & Francis, Boca Raton, FL (2011) . DOI: 10.1201/b10787-14 . PMID: 22593922
Pharmacopeias & Reviews
- [18] Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol (2009) ; 41 : 40-59 . DOI: 10.1016/j.biocel.2008.06.010 . PMID: 18662800
- [19] Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J Altern Complement Med (2003) ; 9 : 161-168 . DOI: 10.1089/107555303321223035 . PMID: 12676044
- [20] Hewlings SJ, Kalman DS. Curcumin: A Review of Its Effects on Human Health. Foods (2017) ; 6 : 92 . DOI: 10.3390/foods6100092 . PMID: 29065496
- [21] Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm (2007) ; 4 : 807-818 . DOI: 10.1021/mp700113r . PMID: 17999464
- [22] Rivera-Espinoza Y, Muriel P. Pharmacological actions of curcumin in liver diseases or damage. Liver Int (2009) ; 29 : 1457-1466 . DOI: 10.1111/j.1478-3231.2009.02086.x . PMID: 19811613
- [23] Moghadamtousi SZ, Kadir HA, Hassandarvish P, Tajik H, Abubakar S, Zandi K. A Review on Antibacterial, Antiviral, and Antifungal Activity of Curcumin. Biomed Res Int (2014) ; 2014 : 186864 . DOI: 10.1155/2014/186864 . PMID: 24877064
- [24] Jayaprakasha GK, Jaganmohan Rao L, Sakariah KK. Chemistry and biological activities of C. longa. Trends Food Sci Technol (2005) ; 16 : 533-548 . DOI: 10.1016/j.tifs.2005.08.006
Last updated: 2026-02-26 | Status: review